Canada should allow patents on higher life forms —other than humans — and amend its Patent Act to allow for research and experimental use of patented processes and products. These recommendations were among 13 included in the final report of the Canadian Biotechnology Advisory Committee, which was released June 7 prior to the opening of the Bio2002 conference in Toronto.